Accepted for Publication: August 18, 2020.
Corresponding Author: Nan-shan Zhong, MD, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Rd, Guangzhou, Guangdong 510120, China (firstname.lastname@example.org).
Published Online: September 10, 2020. doi:10.1001/jamainternmed.2020.5503
Author Contributions: Drs Lin-ling Cheng and Duan had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Lin-ling Cheng, Guan, and Duan are co–first authors. Dr Zhong was the guarantor of the study.
Concept and design: L-l. Cheng, Duan, N-f. Zhang, A-l. Chen, S-y. Li, Zhuo, J-h. Zhang, P-y. Chen, C-y. Wang, Zhong.
Acquisition, analysis, or interpretation of data: L-l. Cheng, Guan, Duan, Lei, Hu, Deng, F-j. Cheng, Gao, J-h. Zhang, Xie, Hong Peng, Y-s. Li, Wu, Liu, Hui Peng, J. Wang, Xiao, P-y. Chen, Yang, Zhao, Zhong.
Drafting of the manuscript: L-l. Cheng, Guan, N. Zhang, Lei, A. Chen, S-y. Li, J-h. Zhang, Xie, Hong Peng, Hui Peng, J. Wang, P-y. Chen, Zhong.
Critical revision of the manuscript for important intellectual content: L-l. Cheng, Guan, Duan, Lei, Hu, Zhuo, Deng, F-j. Cheng, Gao, J. Zhang, Y-s. Li, Wu, Liu, Xiao, P-y. Chen, C-y. Wang, Yang, Zhao, Zhong.
Statistical analysis: Duan, J-h. Zhang, Wu, Liu, P-y. Chen.
Obtained funding: L-l. Cheng, J-h. Zhang.
Administrative, technical, or material support: L-l. Cheng, N-f. Zhang, Lei, Hu, A-l. Chen, S-y. Li, Zhuo, Deng, Gao, J-h. Zhang, Xie, Y. Li, Wu, J. Wang, Xiao, C-y. Wang, Yang, Zhao, Zhong.
Supervision: L-l. Cheng, N-f. Zhang, J-h. Zhang, Zhong.
Conflict of Interest Disclosures: Dr L. Cheng reported grants from Guangzhou Institute of Respiratory Health during the conduct of the study. No other disclosures were reported.
Funding/Support: The study was supported by grants related to the prevention and management of coronavirus disease 2019 and Guangzhou Institute for Respiratory Health. We thank Kyowa Hakko Kirin China Pharmaceutical Co Ltd for their provision of the recombinant human granulocyte colony-stimulating factor.
Role of the Funder/Sponsor: The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Data Sharing Statement: See Supplement 4.
H , Guo
M , Sun
et al. Effects of recombinant human granulocyte colony-stimulating factor on central and peripheral T lymphocyte reconstitution after sublethal irradiation in mice. J Radiat Res
. 2013;54(1):83-91. doi:10.1093/jrr/rrs082
T , Kubo
K , Koyama
et al. Neutrophils pretreated with granulocyte colony-stimulating factor (G-CSF) are not related to the severity of endotoxin-induced lung injury. Exp Lung Res
. 1997;23(5):393-404. doi:10.3109/01902149709039234
SS , Fang
S , Zhu
CY , Wang
LL , Gao
CJ . Effect of G-CSF in vitro stimulation on distribution of peripheral lymphocyte subsets in the healthy persons [article in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2018;26(1):258-262.PubMedGoogle Scholar
GK , Ersvaer
E , Eide
GE , Kristoffersen
EK , Bruserud
Ø . Peripheral blood stem cell mobilization in healthy donors by granulocyte colony-stimulating factor causes preferential mobilization of lymphocyte subsets. Front Immunol
. 2018;9:845. doi:10.3389/fimmu.2018.00845
D , Raspadori
D , Anasetti
et al. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant
. 1998;22(7):631-637. doi:10.1038/sj.bmt.1701413
International Severe Acute Respiratory and Emerging Infections Consortium. ISARIC home page. Accessed September 1, 2020. https://isaric.tghn.org/